Maximum quantity allowed is 999
请选择数量
CAS RN: 86393-32-0 | 產品號碼: C2227
Ciprofloxacin Hydrochloride Monohydrate
×
![]()
×
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | C2227 |
| 純度/分析方法 | >98.0%(T)(HPLC) |
| 分子式 / 分子量 | C__1__7H__1__8FN__3O__3·HCl·H__2O = 385.83 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
| 應避免的情況 | Light Sensitive |
| CAS RN | 86393-32-0 |
| 相關CAS RN | 85721-33-1 |
| Reaxys-RN | 4627629 |
| PubChem Substance ID | 87560207 |
| SDBS (AIST Spectral DB) | 52167 |
| Merck Index(14) | 2314 |
| MDL編號 | MFCD00242856 |
產品規格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Neutralization titration) | min. 98.0 % |
| Water | 4.7 to 6.7 % |
| NMR | confirm to structure |
性質
GHS
相關法規
運輸資料
| HS編碼* | 2933.99-000 |
Application
Quorum sensing research / Biofilm research
References
- Ciprofloxacin-Loaded Mixed Polymeric Micelles as Antibiofilm Agents
- Sub-Inhibitory Concentrations of Ciprofloxacin Alone and Combinations with Plant-Derived Compounds against P. aeruginosa Biofilms and Their Effects on the Metabolomic Profile of P. aeruginosa Biofilms
- Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin
- Subinhibitory concentration of ciprofloxacin targets quorum sensing system of Pseudomonas aeruginosa causing inhibition of biofilm formation & reduction of virulence
- Role of Antibiotic Penetration Limitation in Klebsiella pneumoniae Biofilm Resistance to Ampicillin and Ciprofloxacin
- Investigation of Ciprofloxacin Penetration into Pseudomonas aeruginosa Biofilms
Application
Studies on the Antibacterial Activities of Ciprofloxacin
References
- Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
- Activity of acyclovir, ciprofloxacin and organotin polymers derived from acyclovir and ciprofloxacin against Herpes simplex virus (HSV-1) and Varicella Zoster virus (VZV)
- M. R. Roner, C. E. Carraher, Jr., A. Zhao, J. L. Roehr, K. D. Bassett, D. W. Siegmann-Louda, PMSE Prepr. 2004, 90, 515.
- Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a cooperative drug-DNA binding model
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents
考研文獻
文檔
產品介紹報導
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。